Follow US:
UC Riverside mouse study describes mechanisms underlying sex differences for obesity
Inflammatory bowel disease, or IBD, describes Crohn’s disease and ulcerative colitis, two chronic diseases that cause inflammation in the intestines. IBD, which affects about 3 million adults in the United States, is an autoimmune disorder — a condition in which the body’s immune system attacks healthy tissues. Its symptoms include...
UC Riverside mouse study shows how gene mutation leads to ovaries failing prematurely
UC Riverside mouse study finds paternal exposure to phthalates increases risk of metabolic diseases in progeny
UC Riverside study has health implications for people living around California’s largest lake
Study provides insights into fighting broad range of pathogen’s viral strains
UC Riverside experts answer questions on Americans needing just one COVID-19 booster vaccine each year
UC Riverside experts discuss disease symptoms, vaccines, and anxiety management
UC Riverside vaccine expert David Lo shares his thoughts in a Q&A
SAVE focuses on mutations in SARS-CoV-2 and emerging virus variants
UC Riverside’s Dr. David Lo, a vaccine expert, shares his thoughts
UC Riverside-led study shows how an effective therapy against SARS-CoV-2 could be developed
New method developed by UC Riverside researchers quickly assesses drug potential for rare disorders
Joint effort by UC Riverside and UCLA scientists aims to stop the COVID-19-spreading virus from attacking immune cells
UC Riverside-led team identifies a new host protein interaction that produces a robust immune response to viral infection in birds and may lead to better poultry vaccines
As the COVID-19 pandemic continues, the development of antiviral drug treatments has become a critical weapon in our arsenal against the virus. Harnessing the research and scientific brainpower needed to treat and prevent the next pandemic is the University of California - National Labs Antiviral Treatments Targeting All Coronaviruses and...
UC Riverside mouse study focuses on the receptor TNFR1
UC Riverside research shows gene reactivation can be used to treat Fragile X syndrome
UC Riverside-led mouse study finds a receptor greatly contributes to the harmful effects of plastic-associated chemicals
Lei Stanley Qi of Stanford University will give the 2021 Thomas and Salma Haider Biomedical Breakthrough Lecture at UC Riverside
